ENSARTINIB

Clinical trials for ENSARTINIB explained in plain language.

Never miss a new study

Get alerted when new ENSARTINIB trials appear

Sign up with your email to follow new studies for ENSARTINIB, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New hope for ALK lung cancer patients: targeted pill after radiation may delay progression

Disease control Not yet recruiting

This study tests whether taking ensartinib (a targeted pill) after chemoradiation can help people with ALK-mutated stage III lung cancer that cannot be removed by surgery. About 45 adults who have finished chemoradiation without their cancer getting worse will be randomly assigne…

Matched conditions: ENSARTINIB

Phase: PHASE2 • Sponsor: Shanghai Pulmonary Hospital, Shanghai, China • Aim: Disease control

Last updated May 08, 2026 12:03 UTC

ENSARTINIB

Get alerted when new ENSARTINIB trials appear

New hope for ALK lung cancer patients: targeted pill after radiation may delay progression